Pharma Launch Strategy

Perils of “Silofication”

One of the key success factors we’ve identified in our orphan drug consulting and specialty drug consulting practices after over 50 launches and re-launches of orphan and specialty pharmaceuticals, is that the pharma client must have one overarching integrated strategy and corresponding measure of success for their pharma launch plan or re-launch. If activities across the various organizational segments (aka silos) are not highly coordinated then marketing, sales, sales incentive compensation, payer strategy, reimbursement support services and data and reporting can very often run off in significantly disparate directions, some of which can literally be pulling in opposite directions. BioSolutia calls this phenomenon “silofication”. The larger the organization, the higher the probability that silofication can occur. We have found in our orphan drug consulting and specialty drug consulting experiences, designating clear overall accountability and decision-making is one of the keys to success, as is using BCSDS – the BioSolutia Commercialization Strategy Development System.

Tags: | Categories:  Orphan Drug Launch StrategyPharma Launch StrategySpecialty Drug Consulting

Pharma Launch Strategy for Drug Commercialization

Numerous clients come to BioSolutia’s pharma consulting practice looking to duplicate what another product has done in terms of their pharma launch strategy eg. reimbursement support services (hub), specialty pharmacy distribution, patient assistance programs, clinical support services, etc. The issue is every pharma launch or product commercialization situation is different and requires a uniquely customized strategy. That’s where BioSolutia’s specialty pharmaceutical consulting services are different. Our expertise lies in having done over 50 pharma launches and re-launches of some of the most unique and successful products in the marketplace. You wouldn’t ask a surgeon to “just do the same thing you did on your last patient” so why would you take a “copycat” approach to your pharma launch strategy. When selecting a firm to provide pharma consulting or specialty pharmaceutical consulting, experience and the ability to develop a strategy specific for your product’s needs in your specific market situation is the key to success. That’s the BioSolutia difference.

Tags: | Categories:  Clinical Support ProgramsPatient Assistance ProgramsPharma Launch StrategyPharma Product CommercializationReimbursement HubSpecialty Pharmacy ConsultingSpecialty Pharmacy Distribution

Special Announcement
BioSolutia is proud to announce we are now part of the CareMetx team.
  >> Click here to read more